Start the conversation
As much as I love to research tech investments and share my finds with you, I also get a charge out of trying out all the new gadgets that come out every year.
After doing some heavy research, I know this newest iDevice is destined to be much more than just another gadget.
However, it's not the watch itself that demonstrates why Apple Inc. (Nasdaq: AAPL) may be the best tech company – and investment – on Earth. It's the way I was able to make that purchase that proves to me the Silicon Valley legend's long record of success is far from over.
I was headed to an appearance on CNBC. And while my driver may have been battling heavy traffic on the San Francisco-Oakland Bay Bridge, I was able to peacefully use my iPad to buy the watch through the online Apple Store – with absolutely no hiccups or other snafus.
So you know that I hopped online and bought an Apple Watch the minute they were available for preorder.
To me, this confirms what I've long been saying: Apple no longer sells products – the company sells an entire tech ecosystem. It sells itself.
After coming to this realization, I updated my prediction on where Apple's stock is headed from here. It's not too late to buy in or add to your position.
Today, I want to share that prediction with you – and show you how the Apple Watch will help us get there…
The Long Game
Since October 30, 2013, I've been predicting Apple's stock price will rise to a split-adjusted price of $1,000 a share by Labor Day 2016.
Opening this morning at $128.10, the stock only needs to gain 11.5% to reach my post-split prediction price of $142.85. But after seeing the company's smartwatch and mentally placing it into Apple's ecosystem, I now believe that the stock will go much higher than that.
Weeks before my latest appearance on CNBC, I had already decided to buy an Apple Watch and had picked out the unit that I can't wait to wear. It's the stainless-steel model with the magnetic Milanese loop band featuring a sophisticated mesh design.
For me, the only real decision was whether to go with the smaller version, with a depth of 38 millimeters, or the bigger, 42-millimeter model. I decided to go with the smaller face because I prefer a sleeker look.
So, when one of the CNBC anchors asked me if I had decided to buy the watch as part of my "market research," I had to laugh. Not only had I spent a good deal of time picking out my watch, but I already had been making plans on how I would use it in my work, my family life, and my "play" time.
This isn't "market research" – this is my life.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.